BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 24, 2008
 |  BC Week In Review  |  Company News  |  Deals

Life Science Pharmaceuticals, Abbott deal

Life Science granted Abbott exclusive, worldwide rights to develop and commercialize ch806 to treat cancer and other indications,...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >